Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.9B | 1.9B | 2.0B | 1.7B |
Cost of revenue | 368M | 456M | 456M | 263M |
Gross profit | 1.5B | 1.4B | 1.6B | 1.4B |
Operating expense | ||||
Research & development | 686M | 606M | 648M | 629M |
Selling general and admin | 426M | 427M | 469M | 385M |
Other operating expenses | — | — | — | — |
Operating income | 398M | 378M | 435M | 366M |
Non operating interest income | ||||
Income | 8M | 43M | — | — |
Expense | 15M | 15M | 14M | — |
Other income expense | 15M | -1M | -22M | -2M |
Pretax income | 407M | 405M | 399M | 394M |
Tax provision | 153M | 112M | 105M | 114M |
Net income | 254M | 293M | 294M | 280M |
Basic EPS | — | 1.1 | 1.1 | 1.1 |
Diluted EPS | — | 1.1 | 1.1 | 1.0 |
Basic average shares | — | 262M | 264M | 266M |
Diluted average shares | — | 265M | 266M | 268M |
EBITDA | 488M | 496M | 586M | 448M |
Net income from continuing op. | 254M | 293M | 294M | 280M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |